Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of...
MONTREAL, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
View ArticleStarton Therapeutics Announces the Launch of STARSILON a Novel Proprietary...
https://www.globenewswire.com/news-release/2024/01/02/2802878/0/en/Starton-Therapeutics-Announces-the-Launch-of-STARSILON-a-Novel-Proprietary-Transdermal-PATCH-Delivery-Platform.htmlPARAMUS, N.J., Jan....
View ArticleClik here to view.
Cannabix Technologies Files Patent for Proprietary Laboratory Drug Analysis...
VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing...
View ArticleGeoVax Announces Issuance of Malaria Vaccine Patent
Patent Covers Multiple Component Vaccine for Both Prevention and Treatment
View ArticleEuropean Patent Office Approves Key Patent for Indaptus Therapeutics’...
Patent will provide additional protection covering a composition targeting any viral infection, including hepatitis B, HIV, and influenza Patent will provide additional protection covering a...
View ArticleFaraday Pharmaceuticals Announces Agreement with FDA on Interim Analysis of...
SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute...
View ArticleDewpoint Therapeutics Filed Multiple Patent Applications with the US Patent...
BOSTON, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc., a biotechnology company that translates the novel science of condensates into breakthrough therapeutics, today announced the filing...
View ArticleADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides...
4Q 2023 Preliminary Unaudited Total Revenue of $72-74 Million
View ArticleAnavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine...
Grant of Its Newest U.S. Patent Expands Anavex’s Intellectual Property Portfolio in Neurologic Indications Grant of Its Newest U.S. Patent Expands Anavex’s Intellectual Property Portfolio in Neurologic...
View ArticleLiquidia Corporation Files Response to United Therapeutics Lawsuit and Files...
MORRISVILLE, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today it filed its answer, affirmative defenses and a partial motion to...
View ArticlePharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
PharmAla announces that its novel P1 molecule has been accepted by USPTO to its accelerated "Patent Prosecution Highway"
View ArticleRoute 92 Medical Announces the 100th Patent for its Neurovascular...
Route 92 Medical announces the receipt of its 100th patent for its rapidly growing portfolio of neuromuscular intervention products.
View ArticleelectroCore Expands Intellectual Property Portfolio
ROCKAWAY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
View ArticleSOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses...
CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and...
View ArticleInterDigital renews license agreements with Panasonic Entertainment &...
WILMINGTON, Del., Jan. 10, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that the company has renewed its...
View ArticleAlgernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent...
VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
View ArticleNEO Battery Materials Files 9th Silicon Anode Patent for Major Manufacturing...
TORONTO, Jan. 11, 2024 (GLOBE NEWSWIRE) -- January 11, 2024 – (TSXV: NBM) (OTCQB: NBMFF)
View ArticleBullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs...
Issued patent provides protection for BF-223 and related compounds Issued patent provides protection for BF-223 and related compounds
View ArticleAtsign Revolutionizes Secure Data Exchange with Groundbreaking atProtocol®...
Atsign® announces the grant of US Patent No. 11,849,053-B2 for the atProtocol.
View Article